Huawei Dong

Dr. Huawei Dong is an Assistant Professor in the Division of Pulmonary Diseases & Critical Care Medicine at the University of California, Irvine School of Medicine. She serves as board-certified pulmonologist and critical care physician specializing in interstitial lung diseases, leading the interstitial lung disease team at UCI Health with expertise in idiopathic pulmonary fibrosis and autoimmune-related cases through collaborative care with rheumatology, cardiology, and thoracic surgery specialists.

Education:

• Medical Degree: Dartmouth University's Geisel School of Medicine
• Residency: Internal Medicine at Cedars-Sinai Medical Center (Chief Resident)
• Fellowship: Pulmonary and Critical Care Medicine at Brigham and Women's Hospital

Her research concentrates on novel pulmonary fibrosis treatments through active clinical trial leadership, addressing interstitial lung disease mechanisms and progressive fibrosis pathways. She publishes findings in peer-reviewed journals and presents at national conferences, with particular focus on connective tissue disease-associated lung disorders and therapeutic interventions for pulmonary hypertension complications.

Professional Leadership:

• Principal Investigator: Phase 3 belimumab trial for interstitial lung disease with connective tissue disease
• Principal Investigator: Phase 3 BMS-986278 trial for progressive pulmonary fibrosis

Dr. Dong maintains active clinical practice at UCI Health facilities while advancing research in pulmonary fibrosis therapeutics, supported by her multidisciplinary approach to complex lung disease management. She is fluent in English and Chinese (Mandarin) for patient communication.